Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
05/2003
05/20/2003US6565874 Polymeric delivery formulations of leuprolide with improved efficacy
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040339A2 Antisense modulation of purinoreceptor p2x¿3?
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040174A2 Substituted amino ketone compounds
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039580A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003WO2003039572A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003WO2003039553A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/15/2003WO2003039531A1 Modified release tamsulosin tablets
05/15/2003WO2003039530A1 Tamsulosin tablets
05/15/2003WO2003039524A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor
05/15/2003WO2003039473A2 Method for treating or preventing inflammatory diseases
05/15/2003WO2003039464A2 Antimuscarinic aerosol
05/15/2003WO2003039451A2 Thiazole pyridazinones as adenosine antagonists
05/15/2003WO2003039446A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
05/15/2003WO2003039434A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
05/15/2003WO2003039231A2 Compounds and methods for treating transplant rejection
05/15/2003WO2002059156A3 Therapeutic compounds structurally-linked to bacterial polypeptides
05/15/2003WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092736 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092716 Antihypoxic agents
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092686 Calibrating therapy dosage
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003US20030092602 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
05/15/2003US20030092176 Ependymal neural stem cells and method for their isolation
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091530 Preventives and/or remedies for hyperphosphatemia
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2472097A1 Antisense modulation of purinoreceptor p2x3
05/15/2003CA2466336A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465862A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465110A1 Tamsulosin tablets
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464614A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003CA2464217A1 Antimuscarinic aerosol
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310250A1 Use of the compound 2-methoxyphenyl-1-methyl-5P-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an antiinflammatory drug with prevention of gastric hypersecretion and renal impairment
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418109A Drugs for complications of diabetes and neuropathy and utilization thereof
05/14/2003CN1418104A Cosmetic use of hop and ornithine
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1416868A Medicine for treating urinary calculus
05/14/2003CN1416813A Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor
05/13/2003US6562857 Cyanopyrroles
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 562